Principal at Decheng Capital and a board member of AnHeart Therapeutics, CardiMED, GRIT Biotechnology, Insight Lifetech, and LYNK Pharmaceuticals.
AnHeart Therapeutics is an orally available small molecule founded in 2018 by Lihua Zheng.
Lynk Pharmaceuticals is a China-based company.
Insight Lifetech is a Shenzhen-based company.